One pill to fight malaria? new drug trial tests Single-Dose treatment
NCT ID NCT07235020
Summary
This study tested a new experimental malaria drug called INE963. It involved 52 adults with uncomplicated malaria to see how quickly a single oral dose could clear the malaria parasites from their blood and to check if it was safe. The goal was to find an effective dose for a simpler treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Banfora, Burkina Faso
-
Novartis Investigative Site
Azaguié, BP 173, Côte d’Ivoire
-
Novartis Investigative Site
Lambaréné, BP 242, Gabon
-
Novartis Investigative Site
Navrongo, VWJ6+8WF, Ghana
-
Novartis Investigative Site
Kisumu, 40100, Kenya
-
Novartis Investigative Site
Kampala, Uganda
Conditions
Explore the condition pages connected to this study.